Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scienion’s sciFLEXARRAYER S11 to be Used by Courtagen

Published: Tuesday, June 26, 2012
Last Updated: Tuesday, June 26, 2012
Bookmark and Share
Courtagen will use sciFLEXARRAYER technology for the production of QPDx® biochips.

Scienion US, Inc. has announced that Courtagen Life Sciences, Inc. will use SCIENION’s sciFLEXARRAYER technology to produce innovative biochips for multiplex immunoassays, and collaborate with Scienion to meet future manufacturing and market needs.

“With its novel protein immunoassay platform, QPDx® BioChip, Courtagen has brought a fantastic product to market which has already proven to be successful for biomarker analysis in a variety of applications. We are very pleased that Courtagen, with its highly experienced team, has decided to use our sciFLEXARRAYER S11 to produce these biochips”, said Dr. Holger Eickhoff, Chief Executive Officer of SCIENION AG.

Dr. Eickhoff continued, “And with our new US subsidiary SCIENION US, Inc. we are well prepared to provide great service and extend the collaboration according to future needs of our new customer.”

Courtagen Life Sciences, Inc. has developed an automated immunoassay system that consists of a self-contained array-based QPDx® BioChip and the Avantra® Q400 Biomarker Workstation.

The system provides a simple and robust solution to the need to translate proteomics discoveries into a clinical setting.

The self-contained BioChip, one step operation, and short time to results make this technology ideally suited for testing at the point of sample collection, enabling real-time application of biomarker results.

The Avantra Q400 is a compact bench top instrument suitable for space limited areas enabling multiplex biomarker analysis for research use only (RUO) at the lab bench or clinical trial site.

“We have been looking for a reliable solution for the reproducible high throughput production of spotted arrays for our QPDx® BioChips,” said Dr. Kate Sheldon, Ph.D., Director of Product Development at Courtagen.

Dr. Sheldon continued, “The SCIENION sciFLEXARRAYER S11 is able to consistently produce high quality arrays that meet our needs, and has the capacity to meet demand as our business grows.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scienion Receives ISO 9001:2008 Certification
Company claims to be one the first biotech companies to be certified according to the latest revision of the standard for quality management systems.
Thursday, February 19, 2009
Scientific News
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!